Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AID-HEART: Anakinra in Stage D Heart Failure
NCT06062966Phase 1Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2024
- Primary completion
- Jun 2026
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of anakinra in heart failure (HF), sponsored by Virginia Commonwealth University. Primary endpoint: High-sensitive C-Reactive Protein at Month 3. Started Feb 2024; status: completed.
02
Drugs
anakinra
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT06062966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06062966.